We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
-$395M
Cap. Flow
+$563M
Cap. Flow %
15.85%
Top 10 Hldgs %
43.38%
Holding
114
New
26
Increased
23
Reduced
23
Closed
40

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$187M
2
PFE icon
Pfizer
PFE
+$168M
3
GILD icon
Gilead Sciences
GILD
+$125M
4
UNH icon
UnitedHealth
UNH
+$125M
5
LLY icon
Eli Lilly
LLY
+$93.4M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$84.3M
2
AAPL icon
Apple
AAPL
+$80.7M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$75.5M
4
LBTYK icon
Liberty Global Class C
LBTYK
+$74M
5
VMW
VMware, Inc
VMW
+$72.2M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Communication Services 6.34%
3 Financials 5.66%
4 Technology 4.95%
5 Consumer Discretionary 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
76
Bausch Health
BHC
$2.25B
– –
-196,511
Closed -$43.7M
BIDU icon
77
Baidu
BIDU
$36.5B
– –
-300,799
Closed -$59.9M
BLUE
78
DELISTED
bluebird bio
BLUE
– –
-9,818
Closed -$21.4M
BRKR icon
79
Bruker
BRKR
$9.79B
– –
-972,911
Closed -$19.9M
CTSH icon
80
Cognizant
CTSH
$24.3B
– –
-815,408
Closed -$49.8M
CYH icon
81
Community Health Systems
CYH
$391M
– –
-259,743
Closed -$13.5M
DAL icon
82
Delta Air Lines
DAL
$58.3B
– –
-538,650
Closed -$22.1M
EFX icon
83
Equifax
EFX
$20.7B
– –
-645,017
Closed -$62.6M
ELV icon
84
Elevance Health
ELV
$81.6B
– –
-513,715
Closed -$84.3M
FLS icon
85
Flowserve
FLS
$9.63B
– –
-783,767
Closed -$41.3M
HAL icon
86
Halliburton
HAL
$26.4B
– –
-1,084,974
Closed -$46.7M
HLF icon
87
Herbalife
HLF
$1.29B
– –
-567,650
Closed -$15.6M
HOUS
88
DELISTED
Anywhere Real Estate
HOUS
– –
-318,018
Closed -$14.9M
HUM icon
89
PUT
Humana
HUM
$44B
– –
-687,100
Closed -$3.81M
ILMN icon
90
Illumina
ILMN
$31B
– –
-250,575
Closed -$53.2M
KPTI icon
91
Karyopharm Therapeutics
KPTI
$159M
– –
-54,773
Closed -$22.4M
HAPN
92
Happen Inc
HAPN
$2.23B
– –
-87,040
Closed -$6.42M
POWI icon
93
Power Integrations
POWI
$3.39B
– –
-69,026
Closed -$1.56M
PTCT icon
94
PTC Therapeutics
PTCT
$6.26B
– –
-116,268
Closed -$4.97M
QRVO icon
95
Qorvo
QRVO
$8.01B
– –
-575,266
Closed -$46.2M
SIMO icon
96
Silicon Motion
SIMO
$8.65B
– –
-67,075
Closed -$2.32M
SLAB icon
97
Silicon Laboratories
SLAB
$7.15B
– –
-63,709
Closed -$3.44M
SMTC icon
98
Semtech
SMTC
$10.7B
– –
-96,267
Closed -$1.91M
SYK icon
99
CALL
Stryker
SYK
$133B
– –
-158,100
Closed -$545K
THC icon
100
CALL
Tenet Healthcare
THC
$21.8B
– –
-965,900
Closed -$3.43M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
AC
AWM Capital Phoenix, Arizona $1.1B AUM 15.03% 1-Year Est. Return

PFM Health Sciences's Q3 2015 Portfolio in Review

As of Q3 2015, PFM Health Sciences held 114 positions worth $3.55B, down 10% from $3.95B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences deployed $563M of net new capital in Q3 2015, opening 26 new positions and adding to 23 existing holdings. Its largest new stake was Allergan plc: 608,789 shares worth $165M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 48% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was BROADCOM CORP CL-A, an estimated $75.5M trimmed.

  • PFM Health Sciences's largest Q3 2015 buy was Allergan plc: 608,789 shares worth $165M.
  • PFM Health Sciences added most to Pfizer in Q3 2015, an estimated $168M increase.
  • PFM Health Sciences's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $75.5M.
  • PFM Health Sciences fully exited Elevance Health in Q3 2015, selling an estimated $84.3M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $3.55B portfolio in Q3 2015.
  • PFM Health Sciences opened 26 new positions and closed 40 in Q3 2015.
  • PFM Health Sciences's portfolio value fell 10% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.